{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:07:28Z","timestamp":1792631248401,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.blre.2020.100719","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T21:26:04Z","timestamp":1591392364000},"page":"100719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Risk factors for hemolytic transfusion reactions resulting from ABO and minor red cell antigen incompatibility: From mislabeled samples to stem cell transplant and sickle cell disease"],"prefix":"10.1016","volume":"45","author":[{"given":"Eric A.","family":"Gehrie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bipin N.","family":"Savani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett S.","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2020.100719_bb0005","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1537-2995.2010.02622.x","article-title":"Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing","volume":"50","author":"Zou","year":"2010","journal-title":"Transfusion."},{"key":"10.1016\/j.blre.2020.100719_bb0010","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/j.1537-2995.2009.02195.x","article-title":"Current incidence and residual risk of hepatitis B infection among blood donors in the United States","volume":"49","author":"Zou","year":"2009","journal-title":"Transfusion."},{"key":"10.1016\/j.blre.2020.100719_bb0015","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1056\/NEJMp1500154","article-title":"The safety of the blood supply--time to raise the bar","volume":"372","author":"Snyder","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2020.100719_bb0020","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1111\/j.1537-2995.2012.03935.x","article-title":"The residual risk of transfusion-related acute lung injury at the American red Cross (2008-2011): limitations of a predominantly male-donor plasma mitigation strategy","volume":"53","author":"Eder","year":"2013","journal-title":"Transfusion."},{"key":"10.1016\/j.blre.2020.100719_bb0025","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1182\/blood-2011-08-370932","article-title":"Transfusion-related acute lung injury: incidence and risk factors","volume":"119","author":"Toy","year":"2012","journal-title":"Blood."},{"key":"10.1016\/j.blre.2020.100719_bb0030","series-title":"The 2017 Annual SHOT Report","author":"Group. PB-MEDPeaobotSHoTSS","year":"2018"},{"key":"10.1016\/j.blre.2020.100719_bb0035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7326\/0003-4819-157-1-201206190-00429","article-title":"Red blood cell transfusion: a clinical practice guideline from the AABB*","volume":"157","author":"Carson","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2020.100719_bb0040","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1309\/C6U7VP87GC030WMG","article-title":"Nearly two decades using the check-type to prevent ABO incompatible transfusions: one institution's experience","volume":"126","author":"Figueroa","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.blre.2020.100719_bb0045","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000154811","article-title":"Hemolytic transfusion reactions","volume":"35","author":"Strobel","year":"2008","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.blre.2020.100719_bb0050","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V104.11.4095.4095","article-title":"Severe acute hemolytic transfusion reaction following ABO-mismatched platelet transfusion: Should ABO-mismatched platelet transfusion policy be evaluated","volume":"104","author":"Zubair","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2020.100719_bb0055","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.1537-2995.1990.30790385515.x","article-title":"Reports of 355 transfusion-associated deaths: 1976 through 1985","volume":"30","author":"Sazama","year":"1990","journal-title":"Transfusion."},{"key":"10.1016\/j.blre.2020.100719_bb0060","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000151350","article-title":"Reactions induced by platelet transfusions","volume":"35","author":"Kiefel","year":"2008","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.blre.2020.100719_bb0065","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1182\/blood-2008-10-167643","article-title":"Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention","volume":"113","author":"Vamvakas","year":"2009","journal-title":"Blood."},{"key":"10.1016\/j.blre.2020.100719_bb0070","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.tmrv.2019.09.006","article-title":"Examining the role of complement in predicting, preventing, and treating hemolytic transfusion reactions","volume":"33","author":"Arthur","year":"2019","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.blre.2020.100719_bb0075","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/bloodadvances.2019001143","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support","volume":"4","author":"Chou","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2020.100719_bb0080","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1111\/trf.13704","article-title":"Detection rate of blood group alloimmunization based on real-world testing practices and kinetics of antibody induction and evanescence","volume":"56","author":"Stack","year":"2016","journal-title":"Transfusion."},{"key":"10.1016\/j.blre.2020.100719_bb0085","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1537-2995.2008.02014.x","article-title":"The persistence and evanescence of blood group alloantibodies in men","volume":"49","author":"Tormey","year":"2009","journal-title":"Transfusion."},{"key":"10.1016\/j.blre.2020.100719_bb0090","doi-asserted-by":"crossref","first-page":"503","DOI":"10.7205\/MILMED-D-02-5808","article-title":"Estimation of combat-related blood group alloimmunization and delayed serologic transfusion reactions in U.S. military veterans","volume":"174","author":"Tormey","year":"2009","journal-title":"Mil Med"},{"key":"10.1016\/j.blre.2020.100719_bb0095","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1046\/j.1423-0410.2003.00313.x","article-title":"An international study of the performance of sample collection from patients","volume":"85","author":"Dzik","year":"2003","journal-title":"Vox Sang"},{"key":"10.1016\/j.blre.2020.100719_bb0100","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/trf.15102","article-title":"Electronic patient identification for sample labeling reduces wrong blood in tube errors","volume":"59","author":"Kaufman","year":"2019","journal-title":"Transfusion."},{"key":"10.1016\/j.blre.2020.100719_bb0105","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1046\/j.1537-2995.1997.37111298088047.x","article-title":"Adherence to a strict specimen-labeling policy decreases the incidence of erroneous blood grouping of blood bank specimens","volume":"37","author":"Lumadue","year":"1997","journal-title":"Transfusion."},{"key":"10.1016\/j.blre.2020.100719_bb0110","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/trf.15160","article-title":"Addressing the identity crisis in healthcare: positive patient identification technology reduces wrong patient events","volume":"59","author":"Callum","year":"2019","journal-title":"Transfusion."},{"key":"10.1016\/j.blre.2020.100719_bb0115","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1111\/trf.14212","article-title":"Medical and economic implications of strategies to prevent alloimmunization in sickle cell disease","volume":"57","author":"Gehrie","year":"2017","journal-title":"Transfusion."},{"key":"10.1016\/j.blre.2020.100719_bb0120","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/ajh.24460","article-title":"Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes","volume":"91","author":"Habibi","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2020.100719_bb0125","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1111\/trf.15227","article-title":"Challenges in the treatment and prevention of delayed hemolytic transfusion reactions with hyperhemolysis in sickle cell disease patients","volume":"59","author":"Dean","year":"2019","journal-title":"Transfusion."},{"key":"10.1016\/j.blre.2020.100719_bb0130","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.tmrv.2015.06.001","article-title":"Hyperhemolysis in patients with Hemoglobinopathies: a single-center experience and review of the literature","volume":"29","author":"Danaee","year":"2015","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.blre.2020.100719_bb0135","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.tracli.2019.03.002","article-title":"Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion","volume":"26","author":"Chonat","year":"2019","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.blre.2020.100719_bb0140","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.bbmt.2013.03.018","article-title":"Clinical guide to ABO-incompatible allogeneic stem cell transplantation","volume":"19","author":"Booth","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2020.100719_bb0145","doi-asserted-by":"crossref","first-page":"8259531","DOI":"10.1155\/2018\/8259531","article-title":"Acute hemolytic transfusion reaction in group B recipient associated with group a apheresis platelet donor: case report and literature review","volume":"2018","author":"Shachner","year":"2018","journal-title":"Case Rep Med"},{"key":"10.1016\/j.blre.2020.100719_bb0150","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/j.1537-2995.2012.03574.x","article-title":"ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions","volume":"52","author":"Karafin","year":"2012","journal-title":"Transfusion."},{"key":"10.1016\/j.blre.2020.100719_bb0155","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.transci.2009.10.013","article-title":"ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies","volume":"42","author":"Josephson","year":"2010","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.blre.2020.100719_bb0160","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1537-2995.2011.03476.x","article-title":"The impact of apheresis platelet manipulation on corrected count increment","volume":"52","author":"Karafin","year":"2012","journal-title":"Transfusion."},{"key":"10.1016\/j.blre.2020.100719_bb0165","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1111\/trf.12498","article-title":"The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment (CME)","volume":"54","author":"Tobian","year":"2014","journal-title":"Transfusion."},{"key":"10.1016\/j.blre.2020.100719_bb0170","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/ajh.24908","article-title":"Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease","volume":"92","author":"Narbey","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2020.100719_bb0175","series-title":"National Healthcare Safety Network Biovigilance Component Hemovigilance Module Surveillance Protocol v2.5.2","author":"National Healthcare Safety Network DoHQP","year":"2018"},{"key":"10.1016\/j.blre.2020.100719_bb0180","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/ccr3.1534","article-title":"Fatal massive hemolysis caused by immunoglobulin M anti-c antibody in a patient with newly diagnosed B-cell acute lymphoblastic leukemia: a case report","volume":"6","author":"Galvez","year":"2018","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.blre.2020.100719_bb0185","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/bmt.2013.196","article-title":"Minor RBC Ab and allo-SCT","volume":"49","author":"Booth","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2020.100719_bb0190","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/vox.12621","article-title":"A multicentre study investigating vital sign changes occurring in complicated and uncomplicated transfusions","volume":"113","author":"Gehrie","year":"2018","journal-title":"Vox Sang"},{"key":"10.1016\/j.blre.2020.100719_bb0195","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/trf.13060","article-title":"Variation in vital signs resulting from blood component administration in adults","volume":"55","author":"Gehrie","year":"2015","journal-title":"Transfusion."},{"key":"10.1016\/j.blre.2020.100719_bb0200","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V110.11.4021.4021","article-title":"Red blood cell exchange transfusion (RBCET) in the management of acute hemolytic transfusion reaction (AHTR)","volume":"110","author":"Rose","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2020.100719_bb0205","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/trf.12882","article-title":"Successful use of eculizumab for treatment of an acute hemolytic reaction after ABO-incompatible red blood cell transfusion","volume":"55","author":"Weinstock","year":"2015","journal-title":"Transfusion."},{"key":"10.1016\/j.blre.2020.100719_bb0210","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/trf.13119","article-title":"Eculizumab inhibits hemolysis in a model of ABO-incompatible red blood cell transfusion","volume":"55","author":"Fata","year":"2015","journal-title":"Transfusion."},{"key":"10.1016\/j.blre.2020.100719_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076558","article-title":"Brown recluse spider bite mediated hemolysis: clinical features, a possible role for complement inhibitor therapy, and reduced RBC surface glycophorin a as a potential biomarker of venom exposure","volume":"8","author":"Gehrie","year":"2013","journal-title":"PLoS One"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X20300692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X20300692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T20:28:23Z","timestamp":1759436903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X20300692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":43,"alternative-id":["S0268960X20300692"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2020.100719","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for hemolytic transfusion reactions resulting from ABO and minor red cell antigen incompatibility: From mislabeled samples to stem cell transplant and sickle cell disease","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2020.100719","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100719"}}